Takara Bio Inc

TF2

Company Profile

  • Business description

    Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.

  • Contact

    Nojihigashi 7-4-38 Kusatu
    Shiga
    Otsu520-0058
    JPN

    T: +81 775656920

    http://www.takara-bio.co.jp

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 March 2027

    Employees

    1,779

Stocks News & Analysis

stocks

Big-four bank earnings surge but revenue growth elusive

Shares sell off after results.
stocks

This ASX supermarkets business is now underperforming its largest competitor

Competition restrains long-term margins.
stocks

Apple earnings: Let the iPhone 17 cycle rip

We raise our fair value estimate for Apple stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,923.8030.30-0.34%
CAC 408,028.7586.09-1.06%
DAX 4024,192.7099.68-0.41%
Dow JONES (US)49,361.60137.67-0.28%
FTSE 10010,363.9314.89-0.14%
HKSE26,095.88319.351.24%
NASDAQ25,149.2334.790.14%
Nikkei 22559,513.12228.200.38%
NZX 50 Index13,097.6858.480.45%
S&P 5007,236.045.920.08%
S&P/ASX 2008,697.1028.50-0.33%
SSE Composite Index4,112.164.650.11%

Market Movers